China’s Fosun Pharma To Launch $800 Million Hong Kong IPO In March
This article was originally published in PharmAsia News
Executive Summary
China’s Fosun Pharmaceutical said it plans to launch an initial public offering on the Hong Kong stock market in March, hoping to raise as must as $800 million.